Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.854 EUR | -0.70% | +0.83% | +7.29% |
Business Summary
Number of employees: 307
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug
92.7
%
| 41 | 88.6 % | 47 | 92.7 % | +15.80% |
Parapharmaceutical
4.4
%
| 4 | 7.8 % | 2 | 4.4 % | -37.98% |
Services
3.0
%
| 2 | 3.6 % | 2 | 3.0 % | -9.01% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Greece
48.4
%
| 31 | 67.8 % | 25 | 48.4 % | -21.00% |
European Union
44.7
%
| 12 | 26.5 % | 23 | 44.7 % | +86.44% |
Other Countries
7.0
%
| 3 | 5.7 % | 4 | 7.0 % | +35.18% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 21-11-30 | |
Compliance Officer | - | - | |
Chief Operating Officer | - | - | |
Director/Board Member | - | 02-12-31 | |
Theodora Chavela
LAW | General Counsel | - | 17-12-31 |
Xenofon Economou
AUD | Comptroller/Controller/Auditor | - | 19-04-30 |
Mariza Antonaki
HRO | Human Resources Officer | - | 21-12-31 |
Sales & Marketing | - | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Minas G. Tanes
CHM | Chairman | 84 | 08-12-31 |
Director/Board Member | - | 02-12-31 | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | 74 | - | |
Vicky Kefalas
BRD | Director/Board Member | - | 23-05-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 167,868,482 | 64,041,826 ( 38.15 %) | 0 | 38.15 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+7.29% | 154M | |
+20.81% | 43.34B | |
+20.44% | 21.96B | |
+12.20% | 14.09B | |
+12.97% | 13.64B | |
+39.74% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- LAVI Stock
- Company Lavipharm S.A.